Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. (Q45959391)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 2006

Language	Label	Description	Also known as
English	Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.	scientific article published in September 2006

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

0 references

metabolic syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

Steven M. Haffner

6

object named as

Steven Haffner

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

John J. P. Kastelein

7

object named as

John J P Kastelein

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

Scott M. Grundy

5

object named as

Scott M Grundy

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

author name string

Prakash Deedwania

1

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

Philip Barter

2

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

Rafael Carmena

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

Jean-Charles Fruchart

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

John C LaRosa

8

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

Holly Schachner

9

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

James Shepherd

10

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

David D Waters

11

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

Treating to New Targets Investigators

12

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

language of work or name

0 references

publication date

1 September 2006

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

368

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

919-928

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

9539

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

Clustering of heart disease risk factors in diabetic compared to nondiabetic adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic syndrome and vascular disease: is nature or nurture leading the new epidemic of cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabolic syndrome--a new worldwide definition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome: an analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing prevalence of the metabolic syndrome among u.s. Adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969292-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(06)69292-1

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16962881

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45959391&oldid=2137966312"